* Images for illustrative purposes only
* Brand supplied may vary depending on stock availability
Same-day service available for additional £10, conditions apply.
No appointment or long waiting times
Your information always remains private
All our doctors & pharmacists are qualified & based in the UK
Dispensed by our UK partner pharmacies
Choose from our treatment options or speak to the in-store pharmacist for advice
Complete our free online medical consultation to be reviewed by our Clinical Team
We will notify you when your medication is ready for collection
Vagifem vaginal tablets are a form of HRT (hormone replacement therapy) for women experiencing symptoms of the menopause — in particular, vaginal dryness and discomfort. Vagifem contains the female sex hormone estradiol, which is a form of oestrogen that is exactly like the oestrogen produced by the ovaries. It is used to treat vaginal symptoms of menopause, also known as vaginal atrophy. Vagifem vaginal tablets are tablets that are inserted directly into the vagina using an applicator.
During menopause, oestrogen levels in the body decline. This decline in oestrogen can lead to menopausal symptoms such as hot flushes, difficulty sleeping, night sweats, and reduced libido. Decreased oestrogen levels can also cause the walls of the vagina to thin. This is known as vaginal atrophy and can cause a number of symptoms such as:Itching, irritation or burning; pain during sexual intercourse; vaginal dryness before/during sex; recurring or frequent vaginal or urinary infections; vaginal discomfort.
Vagifem contains estradiol, a type of oestrogen hormone. The vaginal tablets are inserted locally into the vagina. This replaces the lost oestrogen in the vagina and helps to relieve the above symptoms. Vagifem is, therefore, an excellent choice of HRT for women that are affected by vaginal dryness, irritation, pain and problems with urination but do not need treatment for other menopausal symptoms such as hot flushes.
The usual dose is to insert one Vagifem tablet into the vagina once daily for two weeks. This is then reduced to one dose twice a week. Leave 3-4 days between each dose.You should only insert Vagifem tablets into the vagina. You should not take this medication orally.
Each tablet is pre-inserted into a single-use applicator. You will need to open a new applicator for every dose of Vagifem.
The full instructions for how to insert Vagifem can be found in the Patient Information Leaflet that comes with the tablets.
Follow the instructions below to ensure appropriate use of this medication:
Always use this medication exactly as your clinician has told you. Check with our clinical team or your GP or pharmacist if you are not sure.
Medicines and their possible side effects can affect individual people in different ways. The following are some of the side effects that are known to be associated with this medicine. Just because a side effect is stated here, it does not mean that all people using this medicine will experience that or any side effect.
Unlike other hormone replacement therapy, using estradiol vaginal inserts like Vagifem tends to result in fewer, milder side effects. On the whole, these symptoms are less common and less severe than in women who take oral HRT.
Most commonly women who use Vagifem report the following side effects:
If you are concerned about any side effects or you do not feel that they are improving over the first few months you should discuss this with a doctor or pharmacist.
If you experience a severe side effect or have an allergic reaction you must seek medical support from your nearest emergency department as soon as possible.
For full information on side effects and correct use, see the patient information leaflet. If any side effects concern you, or you are experiencing any of the side effects mentioned in the patient information leaflet whilst taking this medication, please contact our clinical team or speak to your GP.
HRT can be very beneficial for women who suffer from menopause symptoms. However, there are risks associated with HRT. You shouldn’t use oestrogen creams or pessaries if:
The above risks are associated with HRT products in general. It is likely that the risks are lower with Vagifem because it is for local treatment in the vagina and very little is absorbed into the bloodstream.
It is important to tell us about any medication you currently take. Vagifem is a local treatment in the vagina which means very little is absorbed into the bloodstream. This means it is unlikely to interact with other medicines. It may affect other treatments applied into the vagina.
The following people are at an even higher risk of developing a blood clot and you should inform our clinical team before using Vagifem if any of them apply to you:
Developing blood clots can be dangerous and life-threatening, and can lead to heart attacks and strokes.If you think you are experiencing symptoms of a blood clot, you must either call 111 or see a doctor straight away.
Vagifem should only be used by postmenopausal women and is not a contraceptive. If you are under 50 years old or have had a menstrual period in the last 12 months, you may still need to use additional contraception to prevent pregnancy.If you become pregnant while using Vagifem, you should stop using this medication and speak to a doctor for advice.
Vagifem is for use in postmenopausal women only. You should not use Vagifem if you are breastfeeding.
Get emergency medical help if you have signs of an allergic reaction to this medication. These include:
It is important that you let us know which prescription, over-the-counter medicines and recreational drugs you are currently taking. You must also tell us about any other medical conditions that you currently have (or had in the past). This will help us ensure the prescribed medication is safe and appropriate for you to take.
For full information on warnings, medication interactions and contraindications, refer to the Patient Information Leaflet. Please read all packaging and the Patient Information Leaflet before taking any new medicine and inform our clinical team or your GP of medicines you are taking or intend to take.